Aravis SA
Aravis is an independent Swiss based venture capital firm. Our funds invest in early stage companies in the Biotech and renewable Energy infrastructure sectors, taking active roles from start up to public. With CHF 279m under management Aravis is one of the largest Swiss Venture investor. Our investors are primarily institutional, family offices as well as corporate. The investment partners are dedicated to their respective sectors bringing their strong experience and solid network for the benefits of portfolio companies. We prefer to take lead investor roles and syndicate financings internationally. Aravis Energy I LP was the first ever approved Swiss Limited partnership by the FINMA, the Swiss financial market supervisory authority.
Investments
| Type of firm | Consulting - Advising Firm |
|---|
| Investment Stages | Early-Stage, Expansion - Development Capital, Seed Capital, Start-up Capital |
|---|
| Industrial Sectors | Biotechnology, Energy, Medical - Life Sciences - Health Related |
|---|
| Geographical Focus | Continental Europe |
|---|
| Type of financing | Equity Financing |
|---|
Company Profile
| Number of Employees in Switzerland | 12 |
|---|
| Capital under Management | CHF 279m |
|---|
| Fund Names | Aravis Venture I, LP; Aravis Biotech II, LP; Aravis Energy I, LP; Aravis Energy II |
|---|
| Number of Portfolio Companies | 17 |
|---|
| Examples of Portfolio Companies | Evolva, Telormedix, Biotie, Symetis |
|---|
| Year of Establishment | 2001 |
|---|
| Size of Investment | CHF 7-10m |
|---|
| Available Funds | yes |
|---|
| Minimum investment considered | CHF 1m |
|---|
| Maximum investment considered | CHF 10m |
|---|
| Source of funds | Fund of Funds, Institutionnal, Familly Offices |
|---|
| Preferred exit route | Trade Sale |
|---|